We took a rigorous approach to testing the safety and efficacy of Bw24. Double-blind patient trials are often reserved for pharmaceutical drugs, but we also decided to go this route for our plant-based OTC formula.
found clinically meaningful reduction 45 in eczema severity (SCORAD)
70% had 60% reduction in severity
significant reductions in symptoms compared to baseline
70% reached 75% improvement
Better Than Rx
statistically significant improvements at 4, 8, and 12-weeks compared to Rx (Calcipotriol)
What Is Bw24?
, , , , , , , , , , , , , , , , , , , , , , ,
Our Dermatologist Leadership Team
Tiffany Mayo, M.D. is a board-certified dermatologist and Assistant Professor of Dermatology at The University of Alabama at Birmingham. She received an undergraduate and master’s degree in Chemistry at Tuskegee University. Dr. Mayo completed her medical degree from Baylor College of Medicine and Dermatology training at The University of Alabama at Birmingham. She is the Director of Dermatology Clinical Research and her clinical interests include skin of color, inflammatory diseases, including atopic dermatitis and psoriasis, and hair and scalp disorders.
Peter Lio, M.D. is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association and has over 150 publications and two textbooks.
Smita Aggarwal, M.D. is a board-certified dermatologist and board-certified pediatric dermatologist. She received her medical degree from the University of Kansas, completed her Dermatology training at Loyola University Medical Center in Chicago, followed by a Pediatric Dermatology fellowship at Lurie Children’s Hospital, affiliated with Northwestern University. She is a Fellow of the American Academy of Dermatology, member of the Chicago Dermatological Society, and the Society for Pediatric Dermatology. Her clinical interests include autoimmune and inflammatory diseases in both the adult and pediatric population, with a focus on atopic dermatitis and psoriasis. She currently practices in downtown Chicago, where she aims to integrate both traditional and complementary treatments in her practice of medicine
Dr. Silverberg completed his undergraduate and medical school training as a part of the highly selective dual B.A./M.D. program at State University of New York Downstate Medical Center, in Brooklyn. He also received his doctorate in neuroimmunology and Master of Public Health degree in biostatistics and epidemiology from the State University of New York Downstate Medical Center.
Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. His publications include more than 600 peer-reviewed articles, abstracts and book chapters and he is known internationally for his work.
He is also an associate editor for the Journal of the American Academy of Dermatology, British Journal of Dermatology and Current Dermatology Reports. Dr. Silverberg is a member of the International Eczema Council, North American Contact Dermatitis Group the American Society of Contact Dermatitis. Dr. Silverberg is also the chair of the annual Revolutionizing Atopic Dermatitis global multidisciplinary conference.